FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

79580006: Adrenal hormone (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
132027012 Adrenal hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
820645017 Adrenal hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
132027012 Adrenal hormone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
132027012 Adrenal hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
820645017 Adrenal hormone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
820645017 Adrenal hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

71 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adrenal hormone Is a Pituitary or adrenal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a Hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Has disposition Adrenal hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a Substance categorized by disposition false Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a hormones et leurs métabolites et précurseurs false Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a Substance with molecular messenger mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Budesonide refill 100dose The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide refill 200dose The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate [respiratory use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 100micrograms/blister disks+disk inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms/blister disks refill (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 100micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 25micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 125micrograms inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 500micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 500micrograms/blister disks refill (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 500micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 0.5mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 2mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms CFC-free inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate [respiratory use 2] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclometasone dipropionate 50micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclometasone dipropionate 100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 250micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate nasal preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fludrocortisone acetate 100 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Deoxycortone pivalate [no preparations] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 500micrograms soluble tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 500 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
bétaméthasone 4 mg/mL, ampoule de 1 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone 20 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone [endocrine use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone acetate+lignocaine hydrochloride 80/20mg/2mL injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
acétate de méthylprednisolone et chlorhydrate de lidocaïne 40/10 mg/1 mL pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
acétate de méthylprednisolone 40mg/mL, fiole de 3 mL de suspension injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
méthylprednisolone 50 mg/mL, flacon de 10 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone 1g/20mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone 500mg injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
méthylprednisolone 1 g, fiole de poudre pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone 16 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
méthylprednisolone 40 mg, fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
méthylprednisolone 125 mg, fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
méthylprednisolone 500 mg, fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
méthylprednisolone 1 g, fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
méthylprednisolone 2 g, fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone acetate 40mg/1mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone acetate 80mg/2mL injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Prednisone 20 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone [endocrine use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Kenalog 80mg/2mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
acétonide de triamcinolone 40 mg/mL, seringue préremplie de 2 mL de suspension injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 40mg/1mL i-m prefilled syringe (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone 40mg/1mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone 80mg/2mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Deflazacort 6 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely deflazacort 30 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Deflazacort 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Systemic steroids + acth The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Local corticosteroid injections The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone acetate [musculoskeletal use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide [musculoskeletal use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 10mg/1mL intra-articular/intradermal injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 50mg/5mL intra-articular/intradermal injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 40mg/1mL intra-articular/intramuscular inj The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone hexacetonide 25mg/5mL injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Corticoster + anti-infl [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate 1 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clobetasone butyrate [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clobetasone butyrate 1 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluorometholone 1 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate [ear] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 50micrograms aqueous nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 100micrograms aqueous nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms aqueous nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 400micrograms single-use nasal drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetate [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 55microgram aqueous nasal spray (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Mometasone furoate monohydrate [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Mometasone furoate monohydrate 0.05% aqueous nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Corticosteroids for oropharynx The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 1 mg/g oromucosal paste The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Topical form corticosteroids The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone creams (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)

Start Page 2 of 6 Next End

This concept is not in any reference sets

Back to Start